CN112220804A - Externally applied medicine for skin - Google Patents

Externally applied medicine for skin Download PDF

Info

Publication number
CN112220804A
CN112220804A CN202011130722.0A CN202011130722A CN112220804A CN 112220804 A CN112220804 A CN 112220804A CN 202011130722 A CN202011130722 A CN 202011130722A CN 112220804 A CN112220804 A CN 112220804A
Authority
CN
China
Prior art keywords
skin
bezoar
wound
healing
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202011130722.0A
Other languages
Chinese (zh)
Inventor
罗张龙
王永进
宋华相
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WUHAN JIANMIN DAPENG PHARMACEUTICAL CO Ltd
Original Assignee
WUHAN JIANMIN DAPENG PHARMACEUTICAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by WUHAN JIANMIN DAPENG PHARMACEUTICAL CO Ltd filed Critical WUHAN JIANMIN DAPENG PHARMACEUTICAL CO Ltd
Priority to CN202011130722.0A priority Critical patent/CN112220804A/en
Publication of CN112220804A publication Critical patent/CN112220804A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37Digestive system
    • A61K35/413Gall bladder; Bile
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Nutrition Science (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention provides an externally applied medicine for skin, which comprises the components of in-vitro cultured bezoar powder. The preparation method comprises the following steps: in vitro cultured calculus bovis is subjected to superfine grinding into 600-mesh fine powder to obtain the calculus bovis powder. The external skin medicament is prepared by cultivating bezoar in vitro, taking the bezoar with the effects of clearing heat and removing toxicity and enhancing the transdermal absorption effect of the medicament, promoting tissue regeneration of a sore without leaving scars, and has special effects of simple and special medicament, is mainly externally used for treating various wound healing and repairing, including but not limited to bedsores, herpes zoster, various sores and ulcers and other skin diseases, and is used for promoting tissue regeneration and healing sores. Can also be used for treating skin wound and wound bleeding, disunion of wound, tissue ulceration and necrosis, infection and suppuration, etc. caused by operation. The invention has simple components and good curative effect, can be directly externally applied to skin, is easier to be absorbed, and has better healing and repairing effects on wound surfaces.

Description

Externally applied medicine for skin
Technical Field
The invention belongs to the technical field of medicines, and particularly relates to an externally applied medicine for skin.
Background
The natural bezoar is gallstone of cattle, is obtained occasionally by depending on cattle slaughtering and is only produced in cattle, the natural incidence rate of the cattle gallstone disease is about 2-3 per mill, and the output of the natural bezoar in China is only about 700kg at most according to the stock-keeping number of cattle in China and the natural incidence rate of the cattle gallstone disease estimated by expert research. The global natural bezoar production is about 3000kg, and only 1/3 of them enters mainland china, and the rest flows into japan, korea, taiwan, etc. Therefore, folk medicine has the saying that calculus bovis is difficult to be obtained because of the availability of gold.
Because the natural bezoar has low yield and large market demand, the bezoar used in China depends on import for a long time and has very high price. In order to avoid the spread of bovine spongiform encephalopathy once in europe, north america and australia at the end of the 20 th century, the national food and drug administration specially issues a document to forbid the import of bovine-derived products, so that the contradiction between supply and demand of natural bezoar is further aggravated, a large amount of smuggling bezoar is caused to fill the market, and serious hidden dangers and threats are brought to the public drug safety.
For a long time, Chinese and foreign medical experts have diligently researched natural bezoar, and the modern medical and pharmaceutical technology is expected to be applied to find a substitute of the natural bezoar. In 1972 and 1989, the national approval of artificial bezoar and cultivated bezoar was provided successively.
1. The artificial bezoar is prepared by simply and physically mixing cow bile powder, cholic acid, hyodeoxycholic acid, taurine, bilirubin and the like. Has obvious difference with the natural bezoar in the aspects of components, physical structure, drug effect and the like, and the content of bilirubin which is the main effective component of the bezoar is only 0.7 percent which is far lower than the standard that the content of natural bezoar is not lower than 35 percent. In addition, some of the Chinese patent medicines using artificial bezoar also have side effects such as dizziness, postural hypotension, nausea, vomiting, dry mouth, rash, etc. which are not possessed by natural bezoar. Therefore, the southeast Asia countries such as Japan have no instruction to take the medicine of the artificial bezoar powder in mouth.
2. The cultivated bezoar is gallstone cultivated by implanting sclerotium into living gallbladder of cattle through surgical operation, and is taken out with core during operation or slaughter. The health department of 2 months in 1990 clearly stipulates that the bilirubin content in cultured bezoar is more than 35% (containing 35%) and can be used as same as that of natural bezoar, the bilirubin content is 18% -35% and can only be used for non-first-aid patent medicine formula, and the bilirubin content is below 18% and can not be used for medicine, in the Wei medicine character [90] No. 9 'Notification about temporary management method of cultured bezoar'. In the seventh and eighty years of the last century, more than 10 manufacturers have produced cultivated bezoar due to high bezoar price and low beef price, but no production permit document and manufacturer have produced cultivated bezoar due to high production cost.
Because the artificial bezoar has poor curative effect and the cultivated bezoar is not produced by people, the two substitutes of the natural bezoar do not really relieve the contradiction of the lack of natural bezoar resources.
The in vitro cultured bezoar is developed by scientific research team of famous medical experts such as Cuofan court ancestor academy and professor Chua Hongjiao in China for thirty years, and is prepared by applying modern biotechnology of high technology, destroying the colloidal balance of ox bile by the action of biological enzyme generated by bacterial fermentation, and simulating the generation mechanism of natural bezoar, and has the same properties, structure, components, content, medicinal effect and clinical curative effect as natural bezoar. Because the natural bezoar has various sources, large individual difference, some microbial parasitic bacteria and other factors, the bezoar cultivated in vitro is better than the natural bezoar in the aspects of stability of main components and medication safety. The in vitro cultured calculus bovis technology realizes the industrialized production of calculus bovis, has short period, low cost and controllable components, and the in vitro cultured calculus bovis can be used as the natural calculus bovis according to the specific prescription of the national food and drug administration.
The problem that the wound surface is not easy to heal and repair after being damaged often occurs in daily life and clinic, for example, the bleeding of the skin wound surface and the wound of a patient caused by bedsore, herpes zoster or pyocutaneous disease, operation and the like is not continuous, the wound is not healed, tissue ulceration and necrosis or infection and suppuration and the like, and the prior external medicine for skin containing bezoar components has complex components and complex preparation method. Aiming at the problem, the invention provides an externally applied skin medicament which has simple components and a simple preparation method, but has good effect.
Disclosure of Invention
The invention provides a skin external medicament, which aims to solve the problems of continuous bleeding, no healing after breakage, tissue ulceration and necrosis, infection and suppuration and the like of skin wounds and wounds caused by bedsores, herpes zoster or pyocutaneous disease, operation and the like and enable the wounds to heal and repair as soon as possible.
An external preparation for skin is prepared from in vitro cultured calculus bovis powder.
A method for preparing skin external preparation comprises micronizing in vitro cultured calculus bovis into 600 mesh fine powder.
A topical skin preparation is used for healing wound.
The skin external preparation is used for treating bedsore, herpes zoster or pyocutaneous disease.
The skin external application is used for treating ceaseless bleeding, disunion of damaged skin and wound, tissue ulceration and necrosis or infection and suppuration of skin wound and wound caused by operation.
The invention has the beneficial effects that: the composition has simple components and good curative effect, can be directly externally applied to skin, is easier to absorb, and has better healing and repairing effects on wound surfaces.
Drawings
Fig. 1(a) is a picture of an abraded wound surface before a patient uses a skin external preparation of the present invention; fig. 1 (B) is a wound surface picture of a patient after using a skin external preparation of the present invention for 3 days; fig. 1(C) is a wound surface picture of a patient 7 days after the patient uses the externally applied skin drug of the present invention.
Detailed Description
Example 1
An external preparation for skin is prepared from in vitro cultured calculus bovis powder. Fig. 1(a) is a picture of an abraded wound surface before a patient uses a skin external preparation of the present invention; fig. 1 (B) is a wound surface picture of a patient after using a skin external preparation of the present invention for 3 days; fig. 1(C) is a wound surface picture of a patient 7 days after the patient uses a skin external preparation of the present invention. As can be seen from the figure, the abraded wound surface of a patient is obviously improved after the patient uses the invention for 3 days, and the wound surface is well healed and basically has no scars after insisting on using the invention for 7 days.
Example 2
A method for preparing skin external preparation comprises micronizing in vitro cultured calculus bovis into 600 mesh fine powder.
The bezoar cultured in vitro is superfine ground into 600 mesh fine powder, can be directly used for external application on skin, is easier to absorb, and has better effect.
The external skin medicament is prepared by cultivating bezoar in vitro, taking the bezoar with the effects of clearing heat and removing toxicity and enhancing the transdermal absorption effect of the medicament, promoting tissue regeneration of a sore without leaving scars, and has special effects of simple and special medicament, is mainly externally used for treating various wound healing and repairing, including but not limited to bedsores, herpes zoster, various sores and ulcers and other skin diseases, and is used for promoting tissue regeneration and healing sores. Can also be used for treating skin wound and wound bleeding, disunion of wound, tissue ulceration and necrosis, infection and suppuration, etc. caused by operation.

Claims (5)

1. An external skin medicine is characterized by comprising in-vitro cultured bezoar powder.
2. A method for preparing skin external medicine is characterized in that the bezoar cultured in vitro is micronized into 600 mesh fine powder to obtain the medicine.
3. A topical skin preparation is used for healing wound.
4. A topical skin preparation according to claim 3 for the treatment of bedsores, herpes zoster or sores.
5. A skin external preparation according to claim 3, for treating bleeding, non-healing of wound, ulceration, necrosis of tissue or suppuration due to surgical operation.
CN202011130722.0A 2020-10-21 2020-10-21 Externally applied medicine for skin Pending CN112220804A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011130722.0A CN112220804A (en) 2020-10-21 2020-10-21 Externally applied medicine for skin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011130722.0A CN112220804A (en) 2020-10-21 2020-10-21 Externally applied medicine for skin

Publications (1)

Publication Number Publication Date
CN112220804A true CN112220804A (en) 2021-01-15

Family

ID=74119137

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011130722.0A Pending CN112220804A (en) 2020-10-21 2020-10-21 Externally applied medicine for skin

Country Status (1)

Country Link
CN (1) CN112220804A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102068502A (en) * 2010-12-12 2011-05-25 任国祚 Skin anti-inflammation and itching relieving ointment

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102068502A (en) * 2010-12-12 2011-05-25 任国祚 Skin anti-inflammation and itching relieving ointment

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
王维山,等: "中药膏剂治疗重度褥疮16例", 《现代中西医结合杂志》 *
王鹏,等: "体外培育牛黄促进肛瘘术后伤口愈合的疗效观察", 《数理医药学杂志》 *

Similar Documents

Publication Publication Date Title
CN110882207B (en) Preparation process and method of essence for skin repair
CN101791283B (en) Cosmetic capable of eliminating striae gravidarum and scars
EA018425B1 (en) Pharmaceutical, disinfectant or preservation extract of trigonella foenum-graecum, method for preparing and use thereof
CN101073539A (en) Skin-moistening composition containing metal sulfur protein for improving acne repair
CN110604810A (en) Hydrolyzed collagen gel for gynecology and preparation method thereof
CN113057930A (en) Mite-removing face cream containing rosemary and preparation method thereof
CN109700998B (en) Compound skin injury regeneration repairing agent and preparation method thereof
US20100310654A1 (en) Homeopathic remedies for use before and after aesthetic injectable and surgical procedures to minimize swelling and bruising
CN111297961A (en) Dong medicine for promoting wound healing
CN111514161B (en) Anti-oral ulcer preparation and application thereof
JP2009269904A (en) Herbal medicinal composition for curing external wound and bedsore and method of manufacturing medicine from the composition
CN106581741A (en) Reconstructed human source collagen paste and preparation method thereof
EP3369428A1 (en) External traditional chinese medicine preparation for diminishing inflammation, relieving pain and promoting fast healing, and preparation method therefor
CN112220804A (en) Externally applied medicine for skin
CN1246021C (en) Non-scar plaster for treating trauma and its preparing process and usage
CN1935267A (en) Wound surface active repair material
CN109731040A (en) A kind of wound remediation composition, preparation method and applications
RU2416425C1 (en) Anti-decubitus oil
CN107865817A (en) A kind of preparation method of the anti-inflammatory Deacne pack liquid containing snail mucus and sodium hyaluronate
WO2018113200A1 (en) External traditional chinese medicine preparation for diminishing inflammation, relieving pain and promoting fast healing, and preparation method therefor
US10232004B2 (en) Pharmaceutical composition based on Centella asiatica (Hydrocotyle asiatica L.) for the treatment of lower limb ulcers
WO2004089430A1 (en) New dressing material promoting recovery of skin wound
CN111743812A (en) Vaginal repair nutrient solution and preparation method thereof
CN110384748A (en) A kind of weapons wound badu shengji powder
CN104906131B (en) A kind of preparation method preventing and treating lamb stomatitis plaster

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20210115

RJ01 Rejection of invention patent application after publication